Clinical studies carried out to date are 
								remarkable. They highlight the significant 
								impact of testosterone on Alzheimer's 
								disease(1-2-3-4-5).
								
								
								However, recent publications of eminent 
								researchers question the effectiveness of 
								androgens in Alzheimer's disease (6-7).
								
								
								How to solve these apparent contradictions?
								
								
								The role of testosterone and androgens to treat 
								and prevent Alzheimer's disease requires a more 
								detailed approach. 
								
								
								
								It seems useful to us to draw attention to the 
								fact that clinical studies are often founded on 
								the research of the testosterone rate in blood, 
								which does not make it possible to have a 
								precise idea of 
								
								
								
								androgens' metabolism. 
								Future studies should go into this field. 
								
								
								
								A testosterone rate in the blood of 1500 ng/100 
								ml can correspond to a pathology. On the other 
								hand, an amount of 350ng/100 ml can be 
								nonpathological and not requiring a hormonal 
								substitution.
								
								
								Clinical studies are often done in double-blind 
								what makes it possible to have a general idea of 
								results while having eliminated subjective 
								factors. They are useful to direct researches.
								
								
								
								
								We would like to draw attention to the hormonal 
								singularity of each person with Alzheimer's 
								disease. It would be advisable to make a 
								detailed study of the 
								
								
								
								androgens' metabolism 
								in each patient.
								
								
								The singular study of androgens 
								
								in each person presenting an Alzheimer's disease 
								makes it possible to prescribe a precise 
								treatment (testosterone is not the only androgen 
								available) and well proportioned.
								
								
								The administration of a standard testosterone 
								amount is often proposed to treat each patient. 
								The singularity of the results for each patient 
								implies a singular androgens' treatment or a 
								possible singular counter-indication for this 
								treatment. Failing this, a single and standard 
								testosterone amount can lead to undesirable 
								effects (7).
								
								
								Disappointments 
								(6) and undesirable effects (7) caused by 
								testosterone are avoided by a better knowledge 
								of androgens' therapy. To consider a standard 
								testosterone amount for each patient is not 
								reasonable (diabetes or the thyroid 
								insufficiency is not treated by a usual insulin 
								dose or a standard dose of thyroxin).